Friday, November 22, 2024
HomeTagsHER2+ Patients

HER2+ Patients

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Biofluidica announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive Next-Generation Liquid Biopsy platform, LiquidScan™ to...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics